Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unapproved drugs could be exported to WTO countries without FDA approval under draft bill.

Executive Summary

UNAPPROVED DRUG EXPORT WITHOUT FDA OKAY WOULD BE ALLOWED under a bill being readied by Rep. Upton (R-Mich.). The bill would repeal FDA export review requirements for unapproved devices and drugs being shipped to World Trade Organization member countries. The "FDA Export Reform and Enhancement Act of 1995" is slated to be introduced the week of March 6. WTO, the international body created to implement the General Agreement on Tariffs & Trade, has 80 members, and membership is pending for 10 additional countries.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025859

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel